The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinicopathological features of pancreatic cancer-related diabetes.
 
Michael Lee
Travel, Accommodations, Expenses - Roche; Roche; Roche; Roche
 
Hui-Li Wong
Research Funding - Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst)
 
Erica S. Tsang
No Relationships to Disclose
 
Sean McKay Fenlon Addison
No Relationships to Disclose
 
James T. Topham
No Relationships to Disclose
 
Joanna Karasinska
No Relationships to Disclose
 
Steve Kalloger
No Relationships to Disclose
 
Jonathan M. Loree
Consulting or Advisory Role - AMGEN; AMGEN; AMGEN; AMGEN; Bayer; Bayer; Bayer; Bayer; Ipsen; Ipsen; Ipsen; Ipsen; Novartis; Novartis; Novartis; Novartis; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
 
David F. Schaeffer
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Robarts Clinical Trials; Robarts Clinical Trials; Robarts Clinical Trials; Robarts Clinical Trials
 
Daniel John Renouf
Honoraria - Celgene; Celgene; Celgene; Celgene; Ipsen; Ipsen; Ipsen; Ipsen; SERVIER; SERVIER; SERVIER; SERVIER; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; SERVIER; SERVIER; SERVIER; SERVIER; Shire; Shire; Shire; Shire
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst)